Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Inpatient care

Study Shows Electronic Health Record-Based Algorithm Does Not Reduce Hospitalization in Patients with Kidney Dysfunction Triad

A recent study published in the New England Journal of Medicine found that an electronic health record-based algorithm and intervention did not lead to reduced hospitalization in patients with chronic kidney disease, type 2 diabetes, and hypertension. The study involved over 11,000 patients and showed that the intervention did not result in better disease control or reduced hospitalization compared to usual care. This research provides valuable insights into the effectiveness of electronic health record-based algorithms and interventions for managing the kidney dysfunction triad.

PeaceHealth to Construct 67,000 Square-Foot Rehab Hospital in Springfield

PeaceHealth has received approval to construct a 67,000-square-foot rehabilitation hospital in Springfield, Oregon. The facility, majority owned by PeaceHealth and operated by LifePoint Rehabilitation, will provide physical, speech, and occupational therapies for individuals who have experienced catastrophic medical events. The estimated cost of the project is $72 million, with completion expected by January 2026. The new hospital will include the region’s first brain injury unit and address a significant community need for inpatient rehabilitation services.

Study Finds Inappropriate Diagnosis of Pneumonia Common in Hospitalized Adults

Inappropriate diagnosis of community-acquired pneumonia (CAP) in hospitalized adults is common, especially among older adults and those with dementia, according to a study published in JAMA Internal Medicine. The study found that 12.0 percent of hospitalized patients treated for CAP met criteria for inappropriate diagnosis, with 87.6 percent receiving full antibiotic courses. The study highlights the importance of accurate diagnosis and appropriate antibiotic treatment to minimize the risks associated with underdiagnosis and overdiagnosis of CAP.

UW Health, UnityPoint Health, and Lifepoint Rehabilitation to Develop Second Inpatient Rehabilitation Hospital in Wisconsin

UW Health, UnityPoint Health – Meriter Hospital, and Lifepoint Rehabilitation are partnering to develop a new freestanding inpatient rehabilitation hospital in Fitchburg, Wis. The facility will offer specialized care for adults recovering from neurological disease, stroke, brain or spinal cord injury, and other conditions. This expansion aims to address the growing need for rehabilitation services in the region, with an anticipated opening in 2026.

RSV Passive Immunization 69% Effective in Protecting Infants

The Eurosurveillance Rapid Communication published a study on January 25, 2024, that concluded Beyfortus™ (Nirsevimab) was about 69% effective at preventing pediatric respiratory syncytial virus (RSV) hospitalizations in infants. This study provides early real-world evidence of nirsevimab immunization protecting infants from severe RSV disease in Luxembourg, with a significant decrease in RSV cases among infants under six months old.

Cedars-Sinai Develops Pioneering Method to Identify Dementia Patients in Hospitals Using Electronic Health Records

Cedars-Sinai, a leading medical institution, has developed a pioneering method to identify hospitalized patients likely to have dementia using electronic health records. This innovative approach aims to improve the care provided to these vulnerable patients. The study, published in the…